2192 logo

Medlive Technology Co., Ltd. Stock Price

SEHK:2192 Community·HK$5.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

2192 Share Price Performance

HK$7.16
-9.10 (-55.97%)
HK$7.16
-9.10 (-55.97%)
Price HK$7.16

2192 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and fair value.

2 Risks
3 Rewards

Medlive Technology Co., Ltd. Key Details

CN¥642.2m

Revenue

CN¥256.7m

Cost of Revenue

CN¥385.4m

Gross Profit

CN¥51.1m

Other Expenses

CN¥334.3m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
0.45
60.02%
52.07%
0%
View Full Analysis

About 2192

Founded
1996
Employees
724
CEO
Liping Tian
WebsiteView website
www.medlive.cn

Medlive Technology Co., Ltd. operates an online professional physician platform in Mainland China and internationally. The company’s precision marketing and corporate solution provides digital marketing, digital detailing, digital marketing consultation, digital content creation, application software development, and other relevant services. Its medical knowledge solution offers medical education and clinical decision support, including licensing software to physicians and other registered users, such as other healthcare professionals and pharmaceutical companies. The company’s intelligent patient management solutions include single disease management services, such as disease knowledge dissemination and treatment compliance monitoring; patient education services comprising content development, application software development, and other related services; and chronic disease management services for breast cancer, lung cancer, ovarian cancer, Parkinson’s, lymphoma, stroke, and diabetes management. In addition, it is involved in the provision of research and development services; provision of internet hospital services; provision of publication and planning services for medicine guidelines and medical consensus; organizing medical exhibition conferences; provision of medical services; and provision of research services to pharmaceutical companies. The company was formerly known as Kingyee Co., Limited and changed its name to Medlive Technology Co., Ltd. in February 2021. The company was founded in 1996 and is headquartered in Beijing, China.

Recent 2192 News & Updates

Analysis Article May 29

Here's Why We Think Medlive Technology (HKG:2192) Might Deserve Your Attention Today

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Recent updates

No updates